Literature DB >> 24870796

BMI1 and TWIST1 downregulated mRNA expression in basal cell carcinoma.

Fatemeh Vand Rajabpour1, Reza Raoofian, Leila Youssefian, Hassan Vahidnezhad, Mostafa Mirshams Shahshahani, Hamidreza Fathi, Pedram Noormohammadpour, Kambiz Kamyab Hesari, Morteza Hashemzadeh-Chaleshtori, Mina Tabrizi.   

Abstract

BACKGROUND: BMI1, TWIST1 and SNAI2/SLUG have been implicated in aggressive behavior of squamous cell carcinoma (SCC) and melanoma and BMI1 expression could identify subtypes of Merkel cell carcinoma (MCC). However, BMI1, TWIST1 and SNAI2 expression levels in basal cell carcinomas (BCCs) have not been elucidated. We hypothesized BCC could be a good model system to decipher mechanisms which inhibit processes that drive tumor metastasis. The aim of this study was to examine the mRNA expression level of BMI1, TWIST1, and SNAI2 in BCCs.
MATERIALS AND METHODS: Thirty-five fresh non-metastatic BCC tissue samples and seven fresh normal skin tissue samples were evaluated by real-time RT-PCR.
RESULTS: BMI1 and TWIST1 demonstrated marked down-regulation (p<0.00l, p=0.00l respectively), but SNAI2 showed no significant change (p=0.12).
CONCLUSIONS: Previous literature has clearly demonstrated a positive association between BMI1 and TWIST1 expression and metastatic BCC, aggressive SCC and melanoma. Here, we demonstrated a negative association between BMI1 and TWIST1 mRNA expression level and BCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24870796     DOI: 10.7314/apjcp.2014.15.8.3797

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

1.  Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.

Authors:  F Vand-Rajabpour; N Sadeghipour; S Saee-Rad; H Fathi; P Noormohammadpour; M Yaseri; K K Hesari; Z Bagherpour; M Tabrizi
Journal:  Clin Transl Oncol       Date:  2016-10-07       Impact factor: 3.405

2.  Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells.

Authors:  Yang Hong; Chao Shang; Yi-xue Xue; Yun-hui Liu
Journal:  Med Sci Monit       Date:  2015-04-06

3.  Decreased Sox2 Messenger RNA Expression in Basal Cell Carcinoma.

Authors:  Reza Ahmadi-Beni; Fatemeh Vand-Rajabpour; Mohamadreza Ahmadifard; Maryam Daneshpazhooh; Pedram Noormohammadpour; Javad Rahmati; Kambiz Kamyab Hesari; Mehdi Yaseri; Mina Tabrizi
Journal:  Indian J Dermatol       Date:  2020 May-Jun       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.